Eur Respir J 2005; 25:514-520
Copyright ©ERS Journals Ltd 2005
All-cause mortality in males with sleep apnoea syndrome: declining mortality rates with age
P. Lavie,
L. Lavie and
P. Herer
Lloyd Rigler Sleep Apnoea Research Laboratory, B. Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel
CORRESPONDENCE: P. Lavie, Lloyd Rigler Sleep Apnoea Research Laboratory, B. Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel. Fax: 972 48293200. E-mail: plavie@tx.technion.ac.il
Keywords: All-cause mortality, body mass index, males, sleep apnoea
Received: April 30, 2004
Accepted November 18, 2004
The objective of this study was to assess whether an increasing severity of sleep apnoea is associated with increased all-cause mortality hazards and to assess whether the syndrome is associated with excess mortality, in comparison with the general population.
Participants included 14,589 adult males, aged 2093 yrs, referred to the sleep clinics with suspected sleep apnoea or diagnosed with sleep apnoea.
Altogether, 372 deaths were recorded after a median follow-up of 4.6 yrs. The crude all-cause mortality rate was 5.55/1,000 patient yrs, increasing with apnoea severity. Cox proportional analysis revealed that both respiratory disturbance index (RDI) and body mass index significantly influenced all-cause mortality hazard but there was no interaction between them. Males with respiratory disturbance index >30 had a significantly higher mortality hazard rate than the reference group of males with RDI 10. Comparing mortality rates of males with moderate/severe sleep apnoea to the general population revealed that only males aged <50 yrs showed an excess mortality rate.
The hazard of mortality in sleep apnoea increases with apnoea severity as indexed by respiratory disturbance index. Moderate and severe levels of sleep apnoea are moderately associated with an increased risk of all-cause mortality, in comparison with the general population, particularly in males aged <50 yrs. The lack of information about possible confounders and treatment effects should be taken into consideration in the interpretation of these results.
This article has been cited by other articles:

|
 |

|
 |
 
M. A. Martinez-Garcia, J. J. Soler-Cataluna, L. Ejarque-Martinez, Y. Soriano, P. Roman-Sanchez, F. B. Illa, J. M. M. Canal, and J. Duran-Cantolla
Continuous Positive Airway Pressure Treatment Reduces Mortality in Patients with Ischemic Stroke and Obstructive Sleep Apnea: A 5-Year Follow-up Study
Am. J. Respir. Crit. Care Med.,
July 1, 2009;
180(1):
36 - 41.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. F. Garvey, C. T. Taylor, and W. T. McNicholas
Cardiovascular disease in obstructive sleep apnoea syndrome: the role of intermittent hypoxia and inflammation
Eur. Respir. J.,
May 1, 2009;
33(5):
1195 - 1205.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Berger, R. Berger, and A. Oksenberg
Progression of snoring and obstructive sleep apnoea: the role of increasing weight and time
Eur. Respir. J.,
February 1, 2009;
33(2):
338 - 345.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. K. Yaggi
Obstructive Sleep Apnea-Hypopnea Syndrome: Definitions, Epidemiology, and Pathogenesis
ACCP Sleep Med Brd Rev,
January 1, 2009;
4(0):
185 - 192.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Malhotra
Obstructive Sleep Apnea and Central Sleep Apnea: Epidemiology, Pathophysiology, and Risk Factors
ACCP Sleep Med Brd Rev,
January 1, 2009;
4(0):
193 - 200.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. K. Somers, D. P. White, R. Amin, W. T. Abraham, F. Costa, A. Culebras, S. Daniels, J. S. Floras, C. E. Hunt, L. J. Olson, et al.
Sleep Apnea and Cardiovascular Disease: An American Heart Association/American College of Cardiology Foundation Scientific Statement From the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing In Collaboration With the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health)
Circulation,
September 2, 2008;
118(10):
1080 - 1111.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. K. Somers, D. P. White, R. Amin, W. T. Abraham, F. Costa, A. Culebras, S. Daniels, J. S. Floras, C. E. Hunt, L. J. Olson, et al.
Sleep Apnea and Cardiovascular Disease: An American Heart Association/American College of Cardiology Foundation Scientific Statement From the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing In Collaboration With the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health)
J. Am. Coll. Cardiol.,
August 19, 2008;
52(8):
686 - 717.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. V. Fragoso, K. L. B. Araujo, P. H. V. Ness, and R. A. Marottoli
Prevalence of Sleep Disturbances in a Cohort of Older Drivers
J. Gerontol. A Biol. Sci. Med. Sci.,
July 1, 2008;
63(7):
715 - 723.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J Amit Benjamin and K E Lewis
Sleep-disordered breathing and cardiovascular disease
Postgrad. Med. J.,
January 1, 2008;
84(987):
15 - 22.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. J. Buchner, B. M. Sanner, J. Borgel, and L. C. Rump
Continuous Positive Airway Pressure Treatment of Mild to Moderate Obstructive Sleep Apnea Reduces Cardiovascular Risk
Am. J. Respir. Crit. Care Med.,
December 15, 2007;
176(12):
1274 - 1280.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. A. Harsch
Metabolic disturbances in patients with obstructive sleep apnoea syndrome
Eur. Respir. Rev.,
December 1, 2007;
16(106):
196 - 202.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Parati, C. Lombardi, and K. Narkiewicz
Sleep apnea: epidemiology, pathophysiology, and relation to cardiovascular risk
Am J Physiol Regulatory Integrative Comp Physiol,
October 1, 2007;
293(4):
R1671 - R1683.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Hernandez, J. Abreu, P. Abreu, A. Castro, and A. Jimenez
Nocturnal melatonin plasma levels in patients with OSAS: the effect of CPAP
Eur. Respir. J.,
September 1, 2007;
30(3):
496 - 500.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Martinez-Garcia, R. Gomez-Aldaravi, J-J. Soler-Cataluna, T. G. Martinez, B. Bernacer-Alpera, and P. Roman-Sanchez
Positive effect of CPAP treatment on the control of difficult-to-treat hypertension
Eur. Respir. J.,
May 1, 2007;
29(5):
951 - 957.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. T. McNicholas, M. R. Bonsignore, and the Management Committee of EU COST ACTION B26
Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities
Eur. Respir. J.,
January 1, 2007;
29(1):
156 - 178.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. M. Hiestand, P. Britz, M. Goldman, and B. Phillips
Prevalence of Symptoms and Risk of Sleep Apnea in the US Population: Results From the National Sleep Foundation Sleep in America 2005 Poll.
Chest,
September 1, 2006;
130(3):
780 - 786.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Munoz, J. Duran-Cantolla, E. Martinez-Vila, J. Gallego, R. Rubio, F. Aizpuru, and G. De La Torre
Severe Sleep Apnea and Risk of Ischemic Stroke in the Elderly
Stroke,
September 1, 2006;
37(9):
2317 - 2321.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 by the European Respiratory Society.
|